Healthpeak Properties (NYSE:DOC) Releases FY 2024 Earnings Guidance

Healthpeak Properties (NYSE:DOC) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 1.800-1.820 for the period, compared to the consensus estimate of 1.800. The company issued revenue guidance of -.

Healthpeak Properties Stock Down 0.8 %

Shares of Healthpeak Properties stock opened at $20.76 on Friday. Healthpeak Properties has a 1 year low of $16.01 and a 1 year high of $23.26. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. The company has a market capitalization of $14.52 billion, a P/E ratio of 44.17, a price-to-earnings-growth ratio of 2.37 and a beta of 1.13. The business has a 50-day moving average of $21.94 and a two-hundred day moving average of $21.35.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The business had revenue of $700.40 million for the quarter, compared to the consensus estimate of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. Healthpeak Properties’s revenue for the quarter was up 25.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.45 earnings per share. As a group, equities analysts predict that Healthpeak Properties will post 1.8 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a $0.30 dividend. The ex-dividend date was Monday, November 4th. This represents a $1.20 annualized dividend and a yield of 5.78%. Healthpeak Properties’s dividend payout ratio is currently 255.32%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on DOC. Wells Fargo & Company dropped their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Royal Bank of Canada lifted their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a “hold” rating to a “buy” rating and upped their price target for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Citigroup lifted their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Finally, Mizuho reduced their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and an average price target of $22.93.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.